Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16286693 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286758 | 0.98 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL81412 | 0.95 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1285195 | 0.89 | TSHR (0.61) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL238023 | 0.88 | TSHR (0.53) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL20492166 | 0.88 | TSHR (0.45) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286805 | 0.87 | TSHR (0.59) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL5698934 | 0.87 | TSHR (0.69) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL28044457 | 0.86 | TSHR (0.50) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL21081906 | 0.85 | TSHR (0.43) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629657-B2 | Lithium ion adsorbents | EMPOWER INNOVATION & TECHNOLOGY LLC (US) | 2026-05-19 | — | — | US | claimed |
| US-11975125-B2 | Medical devices | MICROVENTION, INC. (US) | 2024-05-07 | — | — | US | claimed |
| EP-3860669-B1 | MEDICAL DEVICES | MICROVENTION INC (US) | 2024-04-03 | — | — | EP | claimed |
| US-20230330309-A1 | MEDICAL DEVICES | MICROVENTION, INC. | 2023-10-19 | — | — | US | claimed |
| US-11725136-B2 | Process for manufacturing light absorbing polymer matrix | ESSILOR INTERNATIONAL (FR) | 2023-08-15 | — | — | US | claimed |
| EP-4223409-A1 | LITHIUM ION ADSORBENTS | Conductive Energy Inc. (CA) | 2023-08-09 | — | — | EP | claimed |
| US-20230241581-A1 | LITHIUM ION ADSORBENTS | CONDUCTIVE ENERGY INC. (CA) | 2023-08-03 | — | — | US | claimed |
| US-11597789-B2 | Materials for hydrophilic interaction chromatography and processes for preparation and use thereof for analysis of glycoproteins and glycopeptides | WATERS TECHNOLOGIES CORPORATION (US) | 2023-03-07 | — | — | US | claimed |
| US-11590267-B2 | Medical devices | MICROVENTION, INC. (US) | 2023-02-28 | — | — | US | claimed |
| EP-3505562-B1 | PROCESS FOR MANUFACTURING LIGHT ABSORBING POLYMER MATRIX | ESSILOR INT (FR) | 2022-09-14 | — | — | EP | claimed |
| US-6475347-B1 | High boiling inhibitors for distillable, polymerizable monomers | CROMPTON CORPORATION | 2002-11-05 | — | — | US | claimed |
| US-20020061407-A1 | Abrasion resistant coating composition and coated articles | PPG INDUSTRIES OHIO, INC. | 2002-05-23 | — | — | US | claimed |
| US-6334935-B1 | DISTILLING REACTION SOLUTION CONTAINING (METH)ACRY LOXY-BEARING ALKOXYSILANE IN THIN-LAYER DISTILLATION DEVICE AT SPECIFIED TEMPERATURE AND VACUUM, WHEREIN MIST SEPARATOR IS CONNECTED TO DISTILLATION DEVICE FOR SEPARATING OFF MIST FROM S OLUTION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-01-01 | — | — | US | claimed |
| US-6051097-A | WATER-SOLUBLE CONDENSATION POLYMER OBTAINED BY SUBJECTING A SPECIFIC COPOLYMER HAVING AN ALKOXYL GROUP AND A SPECIFIC ALKOXYSILANE TO HYDROLYSIS-CONDENSATION; BOND NON-SULFUR-CURABLE ELASTOMER MATERIALS TO VARIOUS ADHERENDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-04-18 | — | — | US | claimed |
| EP-0857771-A2 | Aqueous adhesive composition, and bonding process and bonded article making use of the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1998-08-12 | — | — | EP | claimed |
| EP-0818496-A2 | Method for making aqueous emulsions of functionalized organic polymers | DOW CORNING CORPORATION (US) | 1998-01-14 | — | — | EP | claimed |
| US-5700874-A | CONJUGATED DIENE/VINYLAROMATIC HYDROCARBON COPOLYMER MODIFIED WITH ALKOXYSILANE | BRIDGESTONE CORPORATION (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0593297-B1 | Resin composition for coating and paint | HITACHI CHEMICAL CO LTD (JP) | 1997-04-16 | — | — | EP | claimed |
| US-5449716-A | Curable composition of silane and polysiloxanes with catalyst | DOW CORNING CORPORATION (US) | 1995-09-12 | — | — | US | claimed |
| US-4543403-A | .MOISTURE CURABLE SILANE ENDCAPPED ACRYLIC POLYMER, TELECHELIC | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-09-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629657-B2 | Lithium ion adsorbents | ILK, SDC1, LAMTOR3 | TSHR 3614/4885ALDH1A1 2379/4885CYP3A4 2811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.